| August 9 and 16, 2004 | |||||||||
In Print![]() Photos by Leah Gourley
From Focus: Among the fastest growing breast cancers are those that produce an overabundance of the receptor Her2/Neu. It now appears that a tiny enzyme able to latch onto proteins and change their shape plays a critical role in the path toward these and other virulent forms of the disease. By removing this protein, Pin1, from mutant mice that produce the cancer-promoting Her2/Neu, Gerburg Wulf (left), Kun Ping Lu, and colleagues were able to prevent all but a few animals from developing tumors.
|
|
HeadlinesA Blood-thinner Administered Once Daily Prevents DVT Among Hospitalized Patients In National Survey, 45% of Specialists Report a Recent Medical Error Commercialization Deal Boosts Hope for New Sickle-cell Drug Some Cancer Cell Changes Can Be Reversed, Cloning Study Finds MGH Cancer Specialists Propose New Approval Track for Targeted Drugs New Drug Combination Appears Promising for Those With HIV and Hepatitis C Study Finds Near-term Infants at Risk for Significant Health Problems New Study on Huntington's Disease Reveals Pathology and New Treatment Options
|
Spotlight
Student Scene
Lab WorksA multimedia site featuring Harvard Medical research |
||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |